Tumortropic monocyte-mediated delivery of echogenic polymer bubbles and therapeutic vesicles for chemotherapy of tumor hypoxia

Biomaterials

Volumn 71, Issue , 2015, Pages 71-83

  Huang, Wen Chia ^a   Chiang, Wen Hsuan ^a   Cheng, Ya Hui ^a   Lin, Wan Chi ^a   Yu, Ching Fang ^a   Yen, Chia Yi ^a   Yeh, Chih Kuang ^a   Chern, Chorng Shyan ^b   Chiang, Chi Shiun ^a   Chiu, Hsin Cheng ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Cell mediated drug delivery; Co delivery; Tumor hypoxia; Tumortropic monocytes macrophages

Indexed keywords

BLOOD VESSELS; CELL DEATH; CHEMOTHERAPY; FLUORESCENCE IMAGING; FUNCTIONAL POLYMERS; GAMMA RAYS; MAMMALS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; REMOTE CONTROL; TARGETED DRUG DELIVERY; TUMORS;

CELLULAR DELIVERY; CELLULAR TRANSPORT; CO DELIVERIES; FOCUSED ULTRASOUND; INTRAVENOUS ADMINISTRATION; MONOCYTES/MACROPHAGES; TUMOR HYPOXIA; TUMOR RECURRENCES;

CONTROLLED DRUG DELIVERY;

DOXORUBICIN; ECHOGENIC POLYMER BUBBLE; NANOPARTICLE; POLYMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL HYPOXIA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; EX VIVO STUDY; FLUORESCENCE IMAGING; GAMMA RADIATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR RECURRENCE; ULTRASOUND; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; HUMANS; MICE; MICE, INBRED C57BL; MONOCYTES; NEOPLASMS; POLYMERS; TISSUE DISTRIBUTION;

EID: 84941553043     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.08.033     Document Type: Article

References (60)

1. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 2008, 14:1310-1316.
2. Park K. Polysaccharide-based near-infrared fluorescence nanoprobes for cancer diagnosis. Quant. Imaging Med. Surg. 2012, 2:106-113.
3. Sah H., Thoma L.A., Desu H.R., Sah E., Wood G.C. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int. J. Nanomed. 2013, 8:747-765.
4. Danquah M.K., Zhang X.A., Mahato R.I. Extravasation of polymeric nanomedicines across tumor vasculature. Adv. Drug Deliv. Rev. 2011, 63:623-639.
5. Fokas E., McKenna W.G., Muschel R.J. The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies. Cancer Metastasis Rev. 2012, 31:823-842.
6. Heldin C.H., Rubin K., Pietras K., Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat. Rev. Cancer 2004, 4:806-813.
7. Milosevic M., Warde P., Menard C., Chung P., Toi A., Ishkanian A., et al. Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer. Clin. Cancer Res. 2012, 18:2108-2114.
8. Li J.Z., Gao W., Chan J.Y., Ho W.K., Wong T.S. Hypoxia in head and neck squamous cell carcinoma. ISRN Otolaryngol. 2012, 2012:708974.
9. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 2001, 93:266-276.
10. Vaupel P., Mayer A., Briest S., Hockel M. Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. Adv. Exp. Med. Biol. 2005, 566:333-342.
11. Vaupel P., Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004, 9(Suppl. 5):4-9.
12. Manzoor A.A., Lindner L.H., Landon C.D., Park J.Y., Simnick A.J., Dreher M.R., et al. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res. 2012, 72:5566-5575.
13. Tailor T.D., Hanna G., Yarmolenko P.S., Dreher M.R., Betof A.S., Nixon A.B., et al. Effect of pazopanib on tumor microenvironment and liposome delivery. Mol. Cancer Ther. 2010, 9:1798-1808.
14. Dreher M.R., Liu W.G., Michelich C.R., Dewhirst M.W., Yuan F., Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J. Natl. Cancer Inst. 2006, 98:335-344.
15. Murdoch C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104:2224-2234.
16. Brown J.M., William W.R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 2004, 4:437-447.
17. Ikehara Y., Niwa T., Biao L., Ikehara S.K., Ohashi N., Kobayashi T., et al. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 2006, 66:8740-8748.
18. Choi M.R., Stanton-Maxey K.J., Stanley J.K., Levin C.S., Bardhan R., Akin D., et al. A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 2007, 7:3759-3765.
19. Madsen S.J., Baek S.K., Makkouk A.R., Krasieva T., Hirschberg H. Macrophages as cell-based delivery systems for nanoshells in photothermal therapy. Ann. Biomed. Eng. 2012, 40:507-515.
20. Choi J., Kim H.Y., Ju E.J., Jung J., Park J., Chung H.K., et al. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials 2012, 33:4195-4203.
21. Roth J.C., Curiel D.T., Pereboeva L. Cell vehicle targeting strategies. Gene Ther. 2008, 15:716-729.
22. 2+-ion-manipulated, size-selective permeability. Adv. Funct. Mater 2012, 22:2267-2275.
23. Chiang W.H., Huang W.C., Chang C.W., Shen M.Y., Shih Z.F., Huang Y.F., et al. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging. J. Control Release 2013, 168:280-288.
24. Huang W.C., Chen Y.C., Hsu Y.H., Hsieh W.Y., Chiu H.C. Development of a diagnostic polymersome system for potential imaging delivery. Colloids Surf. B Biointerfaces 2015, 128:67-76.
25. Yu C.F., Hong J.H., Chiang C.S. The roles of macrophages and nitric oxide in interleukin-3-enhanced HSV-Sr39tk-mediated prodrug therapy. PLoS One 2013, 8:e56508.
26. Schartl W. Light Scattering from Polymer Solutions and Nanoparticle Dispersions 2007, Springer, Berlin; New York.
27. Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Current Protocols in Immunology 2008, Chapter 14: Unit 14 1. J.E. Coligan (Ed.).
28. Wang C.H., Kang S.T., Lee Y.H., Luo Y.L., Huang Y.F., Yeh C.K. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33:1939-1947.
29. Zagzag D., Lukyanov Y., Lan L., Ali M.A., Esencay M., Mendez O., et al. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab. Investig. 2006, 86:1221-1232.
30. Wang S.C., Hong J.H., Hsueh C., Chiang C.S. Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab. Investig. 2012, 92:151-162.
31. Chiang C.S., Fu S.Y., Wang S.C., Yu C.F., Chen F.H., Lin C.M., et al. Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. Front. Oncol. 2012, 2:89.
32. Tsai C.S., Chen F.H., Wang C.C., Huang H.L., Jung S.M., Wu C.J., et al. Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int. J. Radiat. Oncol. Phys. 2007, 68:499-507.
33. Ruan J., Song H., Li C., Bao C., Fu H., Wang K., et al. DiR-labeled embryonic stem cells for targeted imaging of in vivo gastric cancer cells. Theranostics 2012, 2:618-628.
34. Huang W.C., Chiang W.H., Huang Y.F., Lin S.C., Shih Z.F., Chern C.S., et al. Nano-scaled pH-responsive polymeric vesicles for intracellular release of doxorubicin. J. Drug Target 2011, 19:944-953.
35. Min H.S., Kang E., Koo H., Lee J., Kim K., Park R.W., et al. Gas-generating polymeric microspheres for long-term and continuous in vivo ultrasound imaging. Biomaterials 2012, 33:936-944.
36. Martinez H.P., Kono Y., Blair S.L., Sandoval S., Wang-Rodriguez J., Mattrey R.F., et al. Hard shell gas-filled contrast enhancement particles for colour Doppler ultrasound imaging of tumors. Medchemcomm 2010, 1:266-270.
37. Huang Y.F., Chiang W.H., Tsai P.L., Chern C.S., Chiu H.C. Novel hybrid vesicles co-assembled from a cationic lipid and PAAc-g-mPEG with pH-triggered transmembrane channels for controlled drug release. Chem. Commun. 2011, 47:10978-10980.
38. Brennen C.E. Cavitation and Bubble Dynamics 1995, Oxford University Press, New York; Oxford.
39. Pitt W.G., Husseini G.A., Staples B.J. Ultrasonic drug delivery - a general review. Expert Opin. Drug Deliv. 2004, 1:37-56.
40. Marmottant P., Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003, 423:153-156.
41. Erukova V.Y., Krylova O.O., Antonenko Y.N., Melik-Nubarov N.S. Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin. BBA-Biomembranes 2000, 1468:73-86.
42. Li M.Q., Tang Z.H., Lv S.X., Song W.T., Hong H., Jing X.B., et al. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin. Biomaterials 2014, 35:3851-3864.
43. Wrenn S.P., Dicker S.M., Small E.F., Dan N.R., Mleczko M., Schmitz G., et al. Bursting bubbles and bilayers. Theranostics 2012, 2:1140-1159.
44. Wrenn S.P., Mleczko M., Schmitz G. Phospholipid-stabilized microbubbles: influence of shell chemistry on cavitation threshold and binding to giant uni-lamellar vesicles. Appl. Acoust. 2009, 70:1313-1322.
45. Chen K.J., Liang H.F., Chen H.L., Wang Y.C., Cheng P.Y., Liu H.L., et al. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery. ACS Nano 2013, 7:438-446.
46. Vyas S.P., Singh R., Asati R.K. Liposomally encapsulated diclofenac for sonophoresis induced systemic delivery. J. Microencapsul. 1995, 12:149-154.
47. Unger E.C., McCreery T.P., Sweitzer R.H., Caldwell V.E., Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Investig. Radiol. 1998, 33:886-892.
48. Nyborg W.L. Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med. Biol. 2001, 27:301-333.
49. Burke B., Giannoudis A., Corke K.P., Gill D., Wells M., Ziegler-Heitbrock L., et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 2003, 163:1233-1243.
50. Mantovani A., Savino B., Locati M., Zammataro L., Allavena P., Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 2010, 21:27-39.
51. Lewis C., Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 2005, 167:627-635.
52. Redente E.F., Dwyer-Nield L.D., Merrick D.T., Raina K., Agarwal R., Pao W., et al. Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am. J. Pathol. 2010, 176:2972-2985.
53. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Investig. 2007, 117:1155-1166.
54. Thomas V., Halloran B.A., Ambalavanan N., Catledge S.A., Vohra Y.K. In vitro studies on the effect of particle size on macrophage responses to nanodiamond wear debris. Acta Biomater. 2012, 8:1939-1947.
55. Nalla A.K., Gogineni V.R., Gupta R., Dinh D.H., Rao J.S. Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells in meningioma. Cell. Signal. 2011, 23:1299-1310.
56. Lee W.H., Sonntag W.E., Mitschelen M., Yan H., Lee Y.W. Irradiation induces regionally specific alterations in pro-inflammatory environments in rat brain. Int. J. Radiat. Biol. 2010, 86:132-144.
57. Turner L., Scotton C., Negus R., Balkwill F. Hypoxia inhibits macrophage migration. Eur. J. Immunol. 1999, 29:2280-2287.
58. Maeda H., Sawa T., Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control Release 2001, 74:47-61.
59. Seki T., Fang J., Maeda H. Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application. Cancer Sci. 2009, 100:2426-2430.
60. Chen F.H., Chiang C.S., Wang C.C., Fu S.Y., Tsai C.S., Jung S.M., et al. Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy. Int. J. Radiat. Oncol. 2011, 80:1512-1521.